Clinical Research

Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more
Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.
Late-breaking PCI data challenge the 'time is muscle' paradigm
Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.
Early SAVR in asymptomatic heart patients linked to long-term benefits
New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.
New data point to LAAO as a safe alternative to long-term drug therapy
At the end of the day, one electrophysiologist explained, these decisions should still be made on a case-by-case basis.
PFA associated with heightened stroke risk
PFA is still quite safe overall. However, new data out of EHRA 2026 suggest cardiologists have much to learn about minimizing risk during treatment.

Researchers simulate red blood cells, oxygen flow using low-frequency ultrasound

Scientists from Lithuania said the therapy could be helpful for patients struggling with lung damage from COVID-19.

Isotope used in cancer drug development shipped for clinical trials

Actinium-225 remains in short supply, slowing drug research.

Premature births can be predicted at 23 weeks using ultrasound

The method was developed based on 22 years of research and has been shown effective in a new study.

UVA Health receives $3.1M grant for using ultrasound to deliver drugs into the brain

Researchers are aiming to use ultrasound to breach the blood-brain barrier and deliver drug therapies.

Samin Sharma, MD, director of interventional cardiology and director of clinical cardiology, Mount Sinai Hospital, New York, discusses the first-in-human use of the Magenta Elevate percutaneous left ventricular assist device (pLVAD) with a small 10 French size and 5.5 liters per minute of hemodynamic support.

Initial results promising for world's smallest percutaneous heart pump

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.

Pre-clinical images of the Abbott Volt pulsed field ablation system creating lesions using electroporation, presented at the 2023 AHA Scientific Sessions, The Abbott PFA system is now being used in a first-in-human study at the Centre for Heart Rhythm Disorders at the University of Adelaide, Australia.

First patients treated with Abbott’s pulsed field ablation offering

According to Abbott, its Volt system was specifically designed to address weaknesses seen in other first-generation PFA offerings.

Vanderbilt University Medical Center sign

Vanderbilt scores $3.2M NIH grant to analyze MRI's role in improving epilepsy surgery

The five-year grant builds upon a growing body of research to better identify patients who would benefit from surgical interventions.

weight loss scale overweight obese lose weight pounds

TAVR in patients with severe obesity: Longer hospital stays, higher costs, more health risks

The CDC defines severe obesity, or class III obesity, as any patient with a BMI of 40 or higher. TAVR among these patients is not associated with a lower survival rate, but it does lead to many more risks.

Clinical Research

Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more

Late-breaking PCI data challenge the 'time is muscle' paradigm

Early SAVR in asymptomatic heart patients linked to long-term benefits

New data point to LAAO as a safe alternative to long-term drug therapy

PFA associated with heightened stroke risk